Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

511 indexed citations
published 1999

Countries where authors are citing Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

Specialization
Citations

This map shows the geographic impact of Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. more than expected).

Fields of papers citing Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer..

About Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

This paper, published in 1999, received 511 indexed citations . Written by Toshihiko Kawamori, R Lubet, Vernon E. Steele, Gary J. Kelloff, Chinthalapally V. Rao and B. Seetharami Reddy covering the research area of Pharmacology, Molecular Biology and Molecular Medicine. It is primarily cited by scholars working on Molecular Medicine (316 citations), Molecular Biology (258 citations), Pharmacology (71 citations), Cancer Research (49 citations) and Oncology (45 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w83147191.

Explore hit-papers with similar magnitude of impact